Nanobiotix S.A. (NANO.PA)
Develops nanoparticle cancer treatments to boost radiation therapy effectiveness
32.84-0.07%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+458.5%
The outlook
Nanobiotix is trading near the midpoint of its 52-week range with mixed momentum against its moving averages. Analyst coverage leans constructively, with an average price target about 59% above the current price. The stock's overall sentiment scores in bullish territory, though today's price action is essentially flat.
What’s behind the score
Price trendMixed vs its moving averages
52-week range65% of the way from its 52-week low to high
Price targetAvg target +59% vs current price
Analyst price target
~12-month · 5 analysts52.20average target+59.0% vs now
Now 32.84
Low 40.00High 60.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.67B
52-wk high
47.66
52-wk low
5.66
50-day avg
32.87
200-day avg
25.35
Trailing P/E
—